HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shin Fujita Selected Research

Adenocarcinoid tumor

7/2010A case of advanced rectal adenocarcinoid tumor with long-term survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shin Fujita Research Topics

Disease

23Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2002
20Neoplasms (Cancer)
01/2022 - 01/2002
19Rectal Neoplasms (Rectal Cancer)
02/2022 - 12/2004
7Lymphatic Metastasis
03/2021 - 10/2008
7Neoplasm Metastasis (Metastasis)
04/2015 - 03/2003
3Colonic Neoplasms (Colon Cancer)
06/2017 - 11/2007
3Adenoma (Adenomas)
09/2012 - 09/2002
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
09/2012 - 09/2002
3Adenocarcinoma
01/2010 - 09/2007
2Intussusception
12/2008 - 10/2007
2Carcinoma (Carcinomatosis)
04/2008 - 01/2007
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2020
1Cecal Neoplasms
05/2015
1Aneurysm (Aneurysms)
05/2015
1Colic (Abdominal Cramps)
05/2015
1Hypokalemia
04/2015
1Liposarcoma
04/2014
1Ulcer
01/2013
1Sepsis (Septicemia)
06/2012
1Anastomotic Leak
06/2012
1Adenocarcinoid tumor
07/2010
1Carcinogenesis
05/2010
1Prostatic Neoplasms (Prostate Cancer)
05/2010
1Lung Diseases (Lung Disease)
01/2010
1Endometriosis
12/2008
1Fibrosis (Cirrhosis)
12/2008
1Wound Infection (Wound Infections)
01/2008
1Margins of Excision
11/2007
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
09/2007
1Microsatellite Instability
12/2005
1Polyps
09/2002

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2013 - 02/2004
4Biomarkers (Surrogate Marker)IBA
09/2012 - 05/2010
3ProteomeIBA
01/2013 - 05/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2009 - 12/2005
2Carcinoembryonic AntigenIBA
01/2022 - 06/2017
2Fluorouracil (Carac)FDA LinkGeneric
09/2009 - 03/2003
2Messenger RNA (mRNA)IBA
09/2007 - 01/2002
1Indicators and Reagents (Reagents)IBA
01/2022
1Alanine Transaminase (SGPT)IBA
04/2015
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2015
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2015
1Cyclin-Dependent Kinase 4IBA
04/2014
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1rho-Associated KinasesIBA
10/2012
1Myosin Type IIIBA
10/2012
1blebbistatinIBA
10/2012
1Carrier Proteins (Binding Protein)IBA
09/2012
1Pharmaceutical PreparationsIBA
05/2011
1MicroRNAs (MicroRNA)IBA
11/2010
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2010
1Plasminogen Activator Inhibitor 1IBA
08/2010
1SuspensionsIBA
08/2010
1C-PeptideIBA
05/2010
1LeptinIBA
05/2010
1AdiponectinIBA
05/2010
1ResistinIBA
05/2010
1AdipokinesIBA
05/2010
1Nicotinamide PhosphoribosyltransferaseIBA
05/2010
1Hormones (Hormone)IBA
05/2010
1A-Form DNA (A-DNA)IBA
01/2009
1Biological ProductsIBA
01/2008
1TinIBA
09/2007
1Indomethacin (Indometacin)FDA LinkGeneric
09/2002
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2002
1hydrogen sulfite (bisulfite)IBA
01/2002

Therapy/Procedure

15Lymph Node Excision (Lymph Node Dissection)
02/2022 - 01/2007
6Adjuvant Chemotherapy
05/2022 - 11/2003
5Operative Surgical Procedures
01/2019 - 07/2006
5Drug Therapy (Chemotherapy)
01/2014 - 03/2003
4Pelvic Exenteration
07/2010 - 12/2004
3Chemoradiotherapy
04/2020 - 09/2011
3Hepatectomy
12/2010 - 12/2006
2Therapeutics
12/2015 - 11/2007
2Colectomy
05/2015 - 03/2010
2Radiotherapy
01/2010 - 11/2007
1Neoadjuvant Therapy
02/2022
1Proctectomy
04/2014
1Lasers (Laser)
01/2013
1Colonic Pouches (S Pouch)
01/2010
1Blood Transfusion (Blood Transfusions)
01/2010
1Appendectomy
12/2008
1Adjuvant Radiotherapy
11/2008
1Vena Cava Filters (Inferior Vena Cava Filter)
10/2008
1Length of Stay
07/2008
1Antibiotic Prophylaxis
01/2008
1Contraindications
10/2007
1Ligation
01/2007
1Withholding Treatment
09/2002
1Colonoscopes
09/2002
1Aftercare (After-Treatment)
09/2002